Related Experiment Videos

Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia

T Ohtsuki1, K Sakurai, H Dou

  • 1Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, 305-8575, Ibaraki, Japan.

Molecular Psychiatry
|April 24, 2001
PubMed

Insights

This study investigated the GRIN2B gene in schizophrenia, finding specific DNA sequence variants associated with the disorder. These findings suggest GRIN2B may play a role in schizophrenia susceptibility.

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • NMDA receptor dysfunction is a potential factor in schizophrenia pathophysiology.
  • The NMDAR2B subunit gene (GRIN2B) is a candidate gene for schizophrenia susceptibility.

Purpose of the Study:

  • To screen for mutations in the GRIN2B gene in Japanese schizophrenia patients.
  • To investigate the association between GRIN2B DNA sequence variants and schizophrenia.

Main Methods:

  • Screening of the GRIN2B coding region in 48 Japanese schizophrenia patients.
  • Association study of identified variants in 268 patients and 337 controls.
  • Analysis of single nucleotide polymorphisms (SNPs) and allele frequencies.

Main Results:

  • Eight synonymous single nucleotide polymorphisms (SNPs) were detected in the GRIN2B gene.
  • A significant excess of homozygosity for 3' region polymorphisms was observed in patients (P = 0.004).
  • Higher frequency of the G allele for the 366C/G polymorphism was found in patients (corrected P = 0.04).

Conclusions:

  • While no NMDAR2B protein variants were found, the study supports GRIN2B's potential role in schizophrenia susceptibility.
  • The findings suggest GRIN2B or a linked locus may confer risk for schizophrenia.
  • Further replication studies are recommended to validate these genetic associations.

Related Concept Videos